| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-09 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.19 | 6e-09 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-07 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |